We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $28B
1-Year Est. Return 44.22%
This Fund
S&P 500
This Quarter Est. Return
+12.04%
1 Year Est. Return
+44.22%
3 Year Est. Return
+129.23%
5 Year Est. Return
+202.08%
10 Year Est. Return
AUM
$26.7B
AUM Growth
+$907M
Cap. Flow
-$222M
Cap. Flow %
-0.83%
Top 10 Hldgs %
19.12%
Holding
5,274
New
860
Increased
1,545
Reduced
1,818
Closed
875

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$311M
2
MSFT icon
Microsoft
MSFT
+$308M
3
TSLA icon
Tesla
TSLA
+$161M
4
PLTR icon
Palantir
PLTR
+$65.9M
5
CRDO icon
Credo Technology Group
CRDO
+$61.2M

Sector Composition

Rank Sector Weight
1 Miscellaneous 59.26%
2 Technology 9.16%
3 Consumer Discretionary 7.99%
4 Healthcare 5.43%
5 Industrials 5.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAP
1501
The Gap Inc
GAP
$7.33B
$2.06M 0.01%
96,374
-689,218
-88% -$14.9M
EFOR
1502
Everforth Inc
EFOR
$1.35B
$2.06M 0.01%
43,522
-93
-0.2% -$4.75K
NKTR icon
1503
Nektar Therapeutics
NKTR
$2.33B
$2.05M 0.01%
+36,107
New +$1.2M
CL icon
1504
CALL
Colgate-Palmolive
CL
$69.9B
$2.05M 0.01%
25,600
-16,800
-40% -$1.43M
FMC icon
1505
PUT
FMC
FMC
$1.28B
$2.04M 0.01%
60,800
-42,100
-41% -$1.64M
LIVN icon
1506
LivaNova
LIVN
$4.29B
$2.04M 0.01%
39,027
+27,202
+230% +$1.37M
RARE icon
1507
Ultragenyx Pharmaceutical
RARE
$1.43B
$2.04M 0.01%
67,933
+63,517
+1,438% +$1.9M
RCKT icon
1508
Rocket Pharmaceuticals
RCKT
$384M
$2.04M 0.01%
625,533
+49,482
+9% +$156K
BLSH
1509
Bullish
BLSH
$5.29B
$2.04M 0.01%
+32,025
New +$1.96M
TRGP icon
1510
CALL
Targa Resources
TRGP
$61.1B
$2.03M 0.01%
12,100
-13,100
-52% -$2.18M
TEVA icon
1511
CALL
Teva Pharmaceutical Industries Limited
TEVA
$45.7B
$2.03M 0.01%
100,300
-8,400
-8% -$148K
CART icon
1512
PUT
Maplebear
CART
$10.5B
$2.02M 0.01%
55,000
+36,900
+204% +$1.7M
BCSS.U
1513
Bain Capital GSS Investment Corp Units
BCSS.U
$2.02M 0.01%
+200,000
New +$2.02M
LHX icon
1514
CALL
L3Harris
LHX
$46.6B
$2.02M 0.01%
6,600
-2,600
-28% -$711K
CLX icon
1515
Clorox
CLX
$10.3B
$2.01M 0.01%
16,339
+13,081
+402% +$1.62M
KMX icon
1516
CarMax
KMX
$8.28B
$2.01M 0.01%
44,747
+44,657
+49,619% +$2.67M
SU icon
1517
CALL
Suncor Energy
SU
$81.3B
$2.01M 0.01%
48,000
-10,200
-18% -$409K
HL icon
1518
PUT
Hecla Mining
HL
$12.7B
$2M 0.01%
165,600
+119,300
+258% +$958K
WBI
1519
WaterBridge Infrastructure LLC
WBI
$1.72B
$2M 0.01%
+79,158
New +$1.86M
FAST icon
1520
CALL
Fastenal
FAST
$56.4B
$2M 0.01%
40,700
-54,200
-57% -$2.56M
SNAP icon
1521
PUT
Snap
SNAP
$9.56B
$2M 0.01%
258,800
-267,800
-51% -$2.22M
ACH
1522
Accendra Health
ACH
$79.2M
$1.99M 0.01%
415,351
+220,896
+114% +$1.41M
WSC icon
1523
PUT
WillScot Mobile Mini Holdings
WSC
$3.32B
$1.99M 0.01%
94,200
+79,500
+541% +$2.05M
LQDA icon
1524
PUT
Liquidia Corp
LQDA
$6.12B
$1.99M 0.01%
87,300
+72,200
+478% +$1.57M
XEL icon
1525
CALL
Xcel Energy
XEL
$46B
$1.98M 0.01%
24,600
+22,800
+1,267% +$1.65M

Similar funds

Walleye Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Walleye Capital held 5,274 positions worth $26.7B, up 3.5% from $25.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Walleye Capital's Q3 2025 filing shows 860 new, 1,545 increased, 1,818 reduced and 875 closed positions. Its largest new stake was Smithfield Foods: 1,645,703 shares worth $38.6M. The largest sale was NVIDIA, an estimated $311M.

By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Walleye Capital's largest Q3 2025 buy was Smithfield Foods: 1,645,703 shares worth $38.6M.
  • Walleye Capital added most to Apple in Q3 2025, an estimated $217M increase.
  • Walleye Capital's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $311M.
  • Walleye Capital fully exited GE Aerospace in Q3 2025, selling an estimated $35.6M.
  • Walleye Capital's ten largest holdings make up 19% of its $26.7B portfolio in Q3 2025.
  • Walleye Capital opened 860 new positions and closed 875 in Q3 2025.
  • Walleye Capital's portfolio value rose 3.5% quarter-over-quarter to $26.7B.

Based on Walleye Capital's 13F filing for Q3 2025, filed 14 Nov 2025.